DCM Shriram Fine Chemicals Limited share price
DCM Shriram Fine Chemicals Limited engages in the manufacturing and selling of chemical products and intermediates in India and internationally. Its Pharma products include D (-) alpha phenyl glycine base, D (-) alpha phenyl glycine ethyl potassium dane salt, D (-) alpha phenyl glycine chloride hydrochloride, D (-) para hydroxy phenyl glycine base, D (-) para hydroxy phenyl glycine methyl potassium dane salt, D (-) para hydroxy phenyl glycine methyl ester, DL 2-(2-Chloro Phenyl) glycine, valine hydantoin, sodium phenoxy acetate, phenoxy acetic acid, phenyl acetic acid, potassium phenyl acetate, sodium phenyl acetate, benzaldehyde, benzyl chloride, benzyl alcohol, benzyl benzoate, benzyl cya…Read more
- Market Cap₹ 236 Cr.
- Current Price₹ 27.18
- High / Low₹ 53 / 17
- Stock P/E—
- Book Value₹ 24
- Dividend Yield1.45 %
- ROCE-0.9 %
- ROE-1.70 %
- Face Value₹ 2.0
More figures (10)
- EPS (TTM)₹ -0.61
- Price / Book1.12
- OPM-0.4 %
- Debt / Equity0.06
- Sales growth (1Y)-10.4 %
- Profit growth (1Y)—
- Promoter holding57.2 %
- EV / EBITDA51.0
- Beta—
- All-time high₹ 53
Price chart
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| DSFCL | +5.55% | +12.27% | +10.85% | — | — | — | — |
| Nifty 50 | -0.31% | -3.85% | -4.34% | -11.42% | -9.53% | +5.46% | +4.76% |
Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.
Quick take
- DCM Shriram Fine Chemicals Limited is in the Specialty Chemicals industry (Basic Materials), with a market value of ₹236 crore.
- Revenue grew -10.4% a year over the last 1 years.
- Return on equity was -1.7% and return on capital employed -0.9% in the latest year.
- Debt was 0.06 times shareholders' equity.
- The share price is 48.2% below its 52-week high.
- Promoters and insiders hold about 57.2%; institutions about 7.6%.
Pros
AI- Company is almost debt-free (debt is 0.06 times equity).
Cons
AINo standout weaknesses in the reported figures.
Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.
AI analysis
Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.
About DCM Shriram Fine Chemicals Limited
DCM Shriram Fine Chemicals Limited engages in the manufacturing and selling of chemical products and intermediates in India and internationally. Its Pharma products include D (-) alpha phenyl glycine base, D (-) alpha phenyl glycine ethyl potassium dane salt, D (-) alpha phenyl glycine chloride hydrochloride, D (-) para hydroxy phenyl glycine base, D (-) para hydroxy phenyl glycine methyl potassium dane salt, D (-) para hydroxy phenyl glycine methyl ester, DL 2-(2-Chloro Phenyl) glycine, valine hydantoin, sodium phenoxy acetate, phenoxy acetic acid, phenyl acetic acid, potassium phenyl acetate, sodium phenyl acetate, benzaldehyde, benzyl chloride, benzyl alcohol, benzyl benzoate, benzyl cyanide, ortho chloro benzaldehyde, ortho chloro benzoic acid, ortho chloro benzyl cyanide, ortho chloro phenyl acetic acid, para chloro benzaldehyde, para chloro benzoic acid, para chloro benzyl cyanide…
- Employees
- 589
- Head office
- New Delhi
Peer comparison
Basic MaterialsSpecialty Chemicals
| S.No. | Company | CMP ₹ | P/E | Mar Cap ₹ Cr | Div Yld % | NP Qtr ₹ Cr | Qtr Profit Var % | Sales Qtr ₹ Cr | Qtr Sales Var % | ROCE % | ROE % | P/B | OPM % | Debt / Eq | Prom. Hold. % | Sales ₹ Cr | Sales Var 3Yrs % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | DCM Shriram Fine Chemicals | 27.18 | — | 236 | 1.45 | 3 | — | 91 | — | -0.9 | -1.7 | 1.12 | -0.4 | 0.06 | 57.23 | 386 | -10.4 |
| 2. | Asian Paints | 2,331.90 | 46.9 | 2,23,546 | 1.17 | 1,539 | 39.96 | 10,521 | 17.89 | 24.4 | 21.2 | 10.47 | 15.8 | 0.18 | 52.90 | 35,541 | 1.1 |
| 3. | Solar Industries India | 20,011.00 | 90.9 | 1,81,080 | 0.06 | 653 | 92.66 | 3,668 | 70.26 | 29.5 | 31.4 | 28.85 | 24.9 | 0.29 | 43.92 | 9,612 | 12.4 |
| 4. | Pidilite Industries | 1,502.80 | 57.8 | 1,53,066 | 0.76 | 884 | 30.29 | 4,552 | 21.27 | 28.5 | 23.8 | 14.12 | 21.6 | 0.04 | 69.28 | 14,601 | 7.4 |
| 5. | Berger Paints India | 473.95 | 45.4 | 55,263 | 0.85 | 404 | 54.30 | 3,584 | 32.53 | 20.6 | 17.2 | 7.99 | 12.6 | 0.09 | 75.60 | 11,790 | 4.2 |
| 6. | Linde India | 6,184.50 | 96.5 | 52,744 | 0.07 | 105 | -11.67 | 694 | 17.32 | 16.3 | 13.6 | 12.36 | 26.7 | 0.02 | 77.98 | 2,530 | 0.3 |
| 7. | Gujarat Fluorochemicals | 4,402.90 | 79.1 | 48,366 | 0.07 | 219 | 19.02 | 1,588 | 23.97 | 9.6 | 7.6 | 6.32 | 17.1 | 0.29 | 66.44 | 4,875 | -4.5 |
| 8. | Himadri Speciality Chemical | 660.70 | 41.5 | 33,337 | 0.12 | 230 | 47.53 | 1,432 | 26.20 | 21.0 | 17.8 | 7.08 | 20.1 | 0.16 | 57.43 | 4,658 | 3.7 |
| 9. | Acutaas Chemicals | 3,206.00 | 68.2 | 26,248 | 0.08 | 74 | 18.85 | 330 | 9.32 | 27.7 | 24.0 | 15.88 | 33.5 | 0.02 | 38.31 | 1,329 | 29.4 |
| 10. | Aether Industries | 1,538.60 | 86.6 | 20,422 | 0.00 | 63 | 33.45 | 327 | 27.49 | 12.1 | 9.4 | 8.31 | 24.0 | 0.19 | 76.58 | 1,160 | 20.2 |
| Median: 44 Co. | 1,935.25 | 39.0 | 8,594 | 0.31 | 224 | 33.45 | 1,510 | 23.97 | 20.8 | 11.3 | 5.19 | 12.3 | 0.13 | 61.94 | 4,767 | 5.5 |
Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.
Quarterly Results
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.
Profit & Loss
Consolidated figures in ₹ croreStandalone figures in ₹ crore /
Projection — your assumptions
Starts from the last four reported quarters (TTM) and applies the figures you enter; growth is pre-filled with the company's own past sales growth. This is a what-if calculator for illustration, not a forecast, estimate or recommendation.
Related party transactions
Related-party transactions are dealings with promoters, directors, subsidiaries and associates. Companies disclose them to the exchanges every half-year and in detail in the notes to their annual report.
No separate related-party filing among the recent announcements of the company.
Full details: notes to the Financial Year 2026 annual report (related party disclosures).
| ₹ Cr | Mar 2026 |
|---|---|
| Sales | 386 |
| 382 | |
| Material Cost % | 60% |
| Employee Cost % | 13% |
| Other Expenses % | 26% |
| Operating Profit | 4 |
| OPM % | 1% |
| Other Income | 3 |
| Interest | 1 |
| Depreciation | 9 |
| Profit before tax | -3 |
| -4 | |
| Profit to shareholders | -4 |
| EPS in Rs | -0.41 |
Return on Equity
- 2 Years:
- 4%
- Last Year:
- -2%
| ₹ Cr | Mar 2026 |
|---|---|
| Sales | 386 |
| 382 | |
| Material Cost % | 60% |
| Employee Cost % | 13% |
| Other Expenses % | 26% |
| Operating Profit | 4 |
| OPM % | 1% |
| Other Income | 2 |
| Interest | 1 |
| Depreciation | 9 |
| Profit before tax | -4 |
| Net Profit | -4 |
| EPS in Rs | -0.49 |
Return on Equity
- 2 Years:
- 4%
- Last Year:
- -2%
Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.
Balance Sheet
Consolidated figures in ₹ crore, as at 31 March
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 17 | |
| Reserves | 215 | 194 |
| 13 | 13 | |
| Long term borrowings | 3 | |
| Short term borrowings | 8 | 8 |
| 80 | 72 | |
| Trade payables | 54 | 49 |
| Current liabilities | 75 | 67 |
| Total Liabilities | 308 | 295 |
| 130 | 103 | |
| Gross block | 168 | 148 |
| Accumulated depreciation | 38 | 45 |
| Goodwill & intangibles | 0 | 0 |
| CWIP | 0 | 1 |
| 178 | 192 | |
| Inventories | 50 | 41 |
| Trade receivables | 83 | 70 |
| Cash & equivalents | 0 | 21 |
| Current assets | 173 | 186 |
| Total Assets | 308 | 295 |
Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.
Cash Flows
Consolidated figures in ₹ crore, financial years ending March
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| 15 | 16 | |
| Profit for the year | 19 | -4 |
| Working capital changes | -10 | 13 |
| Direct taxes paid | -10 | -5 |
| 0 | 11 | |
| Fixed assets purchased | -3 | -2 |
| Fixed assets sold | 0 | 21 |
| Investments purchased | -9 | -10 |
| Investments sold | 11 | |
| -15 | -6 | |
| Repayment of borrowings | -5 | -8 |
| Interest paid | -2 | -2 |
| Dividends paid | -6 | |
| Net Cash Flow | 0 | 21 |
| Free Cash Flow | 12 | 14 |
Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.
Ratios
| Ratio | Mar 2025 | Mar 2026 |
|---|---|---|
| ROE | 8.9% | -1.7% |
| ROCE | 11.9% | -0.9% |
| Operating margin | 5.7% | -0.4% |
| Net margin | 4.5% | -0.9% |
| Debt / equity | 0.06 | 0.06 |
| Current ratio | 2.32 | 2.76 |
| Debtor days | 71 | 67 |
| Inventory days | 74 | 64 |
| Days payable | 80 | 78 |
| Cash conversion cycle | 65 | 53 |
| Working capital days | 84 | 113 |
Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.
Shareholding Pattern
Numbers in percentages · as filed with NSE each quarter
- Promoters 50.11%
- FIIs 1.03%
- DIIs 11.36%
- Public 37.50%
| % | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Promoters | 50.11% | 50.11% | 50.11% |
| 1.49% | 1.48% | 1.03% | |
| Foreign portfolio investors (Cat. I) | 1.49% | 1.48% | 1.03% |
| 12.82% | 12.01% | 11.36% | |
| Insurance companies | 4.64% | 4.64% | 4.64% |
| Banks | 0.01% | 0.01% | 0.01% |
| Alternative investment funds | 4.22% | 3.53% | 2.98% |
| 35.58% | 36.40% | 37.50% | |
| Retail (up to ₹2 lakh) | 21.21% | 21.51% | 22.27% |
| HNIs (above ₹2 lakh) | 3.58% | 4.10% | 4.35% |
| NRIs | 1.07% | 1.15% | 1.04% |
| Bodies corporate | 4.39% | 4.30% | 4.35% |
| IEPF | 3.39% | 3.39% | 3.39% |
| No. of Shareholders | 44,490 | 43,570 | 42,493 |
Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.
Mutual funds & institutions holding DCM Shriram Fine Chemicals
| Holder (above 1%) | Stake |
|---|---|
| Life Insurance Corporation Of IndiaInsurance | 4.64% |
| Abakkus Emerging Opportunities Fund-1AIF | 2.86% |
As named in the shareholding pattern for Jun 2026 filed with NSE. Shareholders below 1% are not named in the filing.
Documents
Announcements
- Shareholders meetingDCM Shriram Fine Chemicals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.10-Oct-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018DCM Shriram Fine Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 201808-Oct-2026
- General UpdatesDCM Shriram Fine Chemicals Limited has informed the Exchange regarding adoption of Company's new logo.03-Oct-2026
- Disclosure under SEBI Takeover RegulationsAlok Bansidhar Shriram has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares …01-Oct-2026
- Resignation of Director/KMP/SMPDCM Shriram Fine Chemicals Limited has informed the Exchange about Resignation of Director/KMP/SMP25-Sep-2026
- CessationDCM Shriram Fine Chemicals Limited has informed the Exchange regarding Cessation of Mr. Rohit Bhandari as Independent Director of the company w.e.f. September 24, 2026.25-Sep-2026
- ResignationDCM Shriram Fine Chemicals Limited has informed the Exchange regarding Resignation of Mr. Rohit Bhandari as Independent Director of the company w.e.f. September 24, 2026.25-Sep-2026
- Trading WindowDCM Shriram Fine Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 201521-Sep-2026
- UpdatesDCM Shriram Fine Chemicals Limited has informed the Exchange regarding 'Board comments on fine levied by Exchanges'.21-Sep-2026
- Resignation of Director/KMP/SMPDCM Shriram Fine Chemicals Limited has informed the Exchange about Resignation of Director/KMP/SMP17-Sep-2026
- CessationDCM Shriram Fine Chemicals Limited has informed the Exchange regarding cessation of Mr. Vijay Anand as Independent Director of the company w.e.f. close of business hours on Septem…17-Sep-2026
- ResignationDCM Shriram Fine Chemicals Limited has informed the Exchange regarding Resignation of Mr. Vijay Anand as Independent Director of the company w.e.f. close of business hours on Sept…17-Sep-2026
Annual reports
Credit ratings
Concalls & investor meets
None filed recently.
Filings made by the company with NSE; documents open on NSE's website.
Key dates
- Ex-dividend date
- 1 Jul 2026
- Latest quarter
- 30 Jun 2026
- Financial year end
- 31 Mar 2026
Trade with our broking desk
Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.
Latest news
In the news
No recent coverage found.
From the company (NSE)
- Shareholders meetingDCM Shriram Fine Chemicals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.NSE filing · 10-Oct-2026
- Certificate under SEBI (Depositories and Participants) Regulations, 2018DCM Shriram Fine Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018NSE filing · 08-Oct-2026
- General UpdatesDCM Shriram Fine Chemicals Limited has informed the Exchange regarding adoption of Company's new logo.NSE filing · 03-Oct-2026
- Disclosure under SEBI Takeover RegulationsAlok Bansidhar Shriram has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares …NSE filing · 01-Oct-2026
- Resignation of Director/KMP/SMPDCM Shriram Fine Chemicals Limited has informed the Exchange about Resignation of Director/KMP/SMPNSE filing · 25-Sep-2026
- CessationDCM Shriram Fine Chemicals Limited has informed the Exchange regarding Cessation of Mr. Rohit Bhandari as Independent Director of the company w.e.f. September 24, 2026.NSE filing · 25-Sep-2026
- ResignationDCM Shriram Fine Chemicals Limited has informed the Exchange regarding Resignation of Mr. Rohit Bhandari as Independent Director of the company w.e.f. September 24, 2026.NSE filing · 25-Sep-2026
- Trading WindowDCM Shriram Fine Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015NSE filing · 21-Sep-2026
Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.
Questions about DCM Shriram Fine Chemicals Limited
What is the share price of DCM Shriram Fine Chemicals Limited today?
What is the market cap of DCM Shriram Fine Chemicals Limited?
What is the P/E ratio of DCM Shriram Fine Chemicals Limited?
Is DCM Shriram Fine Chemicals Limited a good investment?
How can I buy DCM Shriram Fine Chemicals Limited shares?
Have a question about this topic?
Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.
Book your free wealth consultation
- 100% free
- No obligation
- Reply within 2 hours
Request received!
Thank you for trusting Plenitude Connect. An expert will contact you shortly. Please check your inbox for details.